L R Prosnitz, L R Farber, J J Fischer, J R Bertino. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdolescentAdultAgedAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useFemaleHodgkin Disease/drug therapyHodgkin Disease/radiotherapyHodgkin Disease/therapyHumansMaleMechlorethamine/administration & dosageMechlorethamine/therapeutic useMiddle AgedPrednisone/administration & dosagePrednisone/therapeutic useProcarbazine/administration & dosageProcarbazine/therapeutic useVinblastine/administration & dosageVinblastine/therapeutic useVincristine/administration & dosageVincristine/therapeutic use
Substances： See more » Antineoplastic AgentsProcarbazineMechlorethamineVincristineVinblastinePrednisone
Year: 1973 PMID： 4689429 DOI： 10.1148/107.1.187
Source DB: PubMed Journal: Radiology ISSN： 0033-8419 Impact factor: 11.105